These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 26210037

  • 21. Sunitinib loaded chitosan nanoparticles formulation and its evaluation.
    Joseph JJ, Sangeetha D, Gomathi T.
    Int J Biol Macromol; 2016 Jan; 82():952-8. PubMed ID: 26522243
    [Abstract] [Full Text] [Related]

  • 22. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.
    Javia A, Thakkar H.
    J Microencapsul; 2017 Nov; 34(7):644-658. PubMed ID: 28862072
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice.
    Sunena, Singh SK, Mishra DN.
    Curr Drug Deliv; 2019 Nov; 16(1):51-58. PubMed ID: 30289074
    [Abstract] [Full Text] [Related]

  • 25. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
    Pawar H, Douroumis D, Boateng JS.
    Colloids Surf B Biointerfaces; 2012 Feb 01; 90():102-8. PubMed ID: 22037474
    [Abstract] [Full Text] [Related]

  • 26. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery.
    Sharma S, Lohan S, Murthy RS.
    Drug Dev Ind Pharm; 2014 Jul 01; 40(7):869-78. PubMed ID: 23600649
    [Abstract] [Full Text] [Related]

  • 27. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies.
    Patil GB, Surana SJ.
    Artif Cells Nanomed Biotechnol; 2017 May 01; 45(3):505-514. PubMed ID: 27017892
    [Abstract] [Full Text] [Related]

  • 28. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.
    Liu S, Ho PC.
    J Pharm Pharmacol; 2017 Nov 01; 69(11):1495-1501. PubMed ID: 28809432
    [Abstract] [Full Text] [Related]

  • 29. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
    Zameer S, Ali J, Vohora D, Najmi AK, Akhtar M.
    J Drug Target; 2021 Feb 01; 29(2):199-216. PubMed ID: 32876502
    [Abstract] [Full Text] [Related]

  • 30. Intranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief.
    Patel D, Naik S, Chuttani K, Mathur R, Mishra AK, Misra A.
    J Drug Target; 2013 Sep 01; 21(8):759-69. PubMed ID: 23879335
    [Abstract] [Full Text] [Related]

  • 31. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
    Ahmad N, Ahmad R, Alam MA, Ahmad FJ.
    Drug Res (Stuttg); 2018 Oct 01; 68(10):584-595. PubMed ID: 29669380
    [Abstract] [Full Text] [Related]

  • 32. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
    Di Gioia S, Trapani A, Mandracchia D, De Giglio E, Cometa S, Mangini V, Arnesano F, Belgiovine G, Castellani S, Pace L, Lavecchia MA, Trapani G, Conese M, Puglisi G, Cassano T.
    Eur J Pharm Biopharm; 2015 Aug 01; 94():180-93. PubMed ID: 26032293
    [Abstract] [Full Text] [Related]

  • 33. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.
    Zhang X, Liu L, Chai G, Zhang X, Li F.
    Drug Dev Ind Pharm; 2013 Nov 01; 39(11):1618-24. PubMed ID: 24087853
    [Abstract] [Full Text] [Related]

  • 34. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.
    Hard SAAA, Shivakumar HN, Redhwan MAM.
    Int J Biol Macromol; 2023 Dec 31; 253(Pt 6):127217. PubMed ID: 37793522
    [Abstract] [Full Text] [Related]

  • 35. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
    Natesan S, Pandian S, Ponnusamy C, Palanichamy R, Muthusamy S, Kandasamy R.
    Int J Biol Macromol; 2017 Nov 31; 104(Pt B):1837-1845. PubMed ID: 28472691
    [Abstract] [Full Text] [Related]

  • 36. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
    Qureshi M, Aqil M, Imam SS, Ahad A, Sultana Y.
    Curr Drug Deliv; 2019 Nov 31; 16(2):123-135. PubMed ID: 30317997
    [Abstract] [Full Text] [Related]

  • 37. Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route.
    Mittal D, Md S, Hasan Q, Fazil M, Ali A, Baboota S, Ali J.
    Drug Deliv; 2016 Nov 31; 23(1):130-9. PubMed ID: 24786489
    [Abstract] [Full Text] [Related]

  • 38. Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery.
    Piazzini V, Landucci E, D'Ambrosio M, Tiozzo Fasiolo L, Cinci L, Colombo G, Pellegrini-Giampietro DE, Bilia AR, Luceri C, Bergonzi MC.
    Int J Biol Macromol; 2019 May 15; 129():267-280. PubMed ID: 30726749
    [Abstract] [Full Text] [Related]

  • 39. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
    Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, Ali J.
    Eur J Pharm Sci; 2013 Feb 14; 48(3):393-405. PubMed ID: 23266466
    [Abstract] [Full Text] [Related]

  • 40. The nasal delivery of nanoencapsulated statins - an approach for brain delivery.
    Clementino A, Batger M, Garrastazu G, Pozzoli M, Del Favero E, Rondelli V, Gutfilen B, Barboza T, Sukkar MB, Souza SA, Cantù L, Sonvico F.
    Int J Nanomedicine; 2016 Feb 14; 11():6575-6590. PubMed ID: 27994459
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.